INCELLIPAN Trademark

Trademark Overview

On Thursday, November 18, 2010, a trademark application was filed for INCELLIPAN with the United States Patent and Trademark Office. The USPTO has given the INCELLIPAN trademark a serial number of 79090255. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, November 19, 2020. This trademark is owned by Novartis AG. The INCELLIPAN trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
incellipan

General Information

Serial Number79090255
Word MarkINCELLIPAN
Filing DateThursday, November 18, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, November 19, 2020
Registration Number3956905
Registration DateTuesday, May 10, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2011

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeqirus UK Limited
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressGB
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, June 6, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, June 6, 2021DEATH OF INTERNATIONAL REGISTRATION
Thursday, August 6, 2020CHANGE OF OWNER RECEIVED FROM IB
Friday, December 7, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Friday, August 31, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, August 31, 2018INVALIDATION PROCESSED
Wednesday, August 15, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 15, 2017CANCELLED SECTION 71
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, October 22, 2011NOTIFICATION PROCESSED BY IB
Wednesday, July 27, 2011FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 27, 2011FINAL DISPOSITION PROCESSED
Thursday, June 9, 2011GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 10, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, February 22, 2011PUBLISHED FOR OPPOSITION
Wednesday, February 2, 2011NOTICE OF PUBLICATION
Tuesday, January 18, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 14, 2011ASSIGNED TO LIE
Friday, January 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 11, 2011ASSIGNED TO EXAMINER
Monday, January 3, 2011APPLICATION FILING RECEIPT MAILED
Saturday, January 1, 2011APPLICATION FILING RECEIPT MAILED
Saturday, January 1, 2011APPLICATION FILING RECEIPT MAILED
Saturday, January 1, 2011APPLICATION FILING RECEIPT MAILED
Tuesday, December 28, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 23, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

incellipan human vaccines